La lipoproteína a (Lp(a)) es una es una lipoproteína similar al c-LDL, formada por una apolipoproteína B100, pero con una proteína adicional llamada apolipoproteína a, con acción antifibrinolítica y trombogénica.
Contact: Olivia Walther, owalther@acc.org, Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve…
AbstractBackgroundConcerns about the efficacy and safety of intensive low-density lipoprotein cholesterol lowering in older patients have led to weaker recommendations in the U.S. guidelines for…
Sports Cardiology will equip you with first-hand experience of cardiovascular evaluation of elite athletes.
Heart disease is the No. 1 killer of women. WHA works to raise awareness, encourage action and drive new research to combat women’s heart disease.
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions.
The ASPC 2025 Congress on CVD Prevention will be held in-person at the Omni Hotel at the Seaport in Boston, MA from August 1-3, 2025!…
BackgroundThe study investigates the prognostic impact of sex and sex‐related differences in patients hospitalized with heart failure with mildly reduced ejection fraction (HFmrEF). More data…
January saw almost every major cardiovascular subspecialty represented among our most-clicked stories of the month.
Secondary prevention medications for cardiovascular diseases are underused globally and additional strategies to increase their use are needed to improve management and r educe premature…
